Phenformin Hydrochloride

CHEMBL1528839 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
241.7 g/mol
LogP
Phase
4

Phenformin hydrochloride is the hydrochloride salt form of phenformin, a biguanide antidiabetic agent that inhibits hepatic gluconeogenesis and activates AMPK signaling pathways. See phenformin for complete pharmacological details.

분자량

241.7200 g/mol

TPSA

103.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.N=C(N)NC(=N)NCCc1ccccc1

InChI

InChI=1S/C10H15N5.ClH/c11-9(12)15-10(13)14-7-6-8-4-2-1-3-5-8;/h1-5H,6-7H2,(H6,11,12,13,14,15);1H

Molecular Formula

C10H16ClN5

HBD / HBA

4 / 1

회전 가능 결합

4

무거운 원자

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Phenformin hydrochloride is the hydrochloride salt form of phenformin, a biguanide antidiabetic agent that inhibits hepatic gluconeogenesis and activates AMPK signaling pathways. See phenformin for complete pharmacological details.

Yes, Phenformin Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1528839. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 13266. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.